Experts foreshadow the risk of Japanese encephalitis in the United States

According to a study by Dr. THOMAS MONSTH in Quigley Biopharma LLC, Japanese encephalitis is a viral disease that leads to severe inflammation of the central nervous system and increases risks in the United States. The research published in the “Magazine Virus”, highlighting the potential consequences of Japanese encephalitis introduced in the United States, including its impact on public health, agriculture, especially the pig industry. The disease is spread by mosquitoes, mainly in Asia and the Pacific. However, due to its high mortality and the nervous system complications of survivors, the possibility of spreading to the Americas has attracted people’s attention.
Dr. Monite and his colleagues explained that Japanese encephalitis passed Culex Mosquito, pigs, and wading birds are used as key amplifies. Although humans are considered to be the host of the dead alley (which means that they do not cause the transmission), if they see in Asia, the virus will still cause serious outbreaks. In Asia, Japanese encephalitis continues to be the main cause of viral encephalitis. Severe lethality is caused every year. In addition, pigs and horses are also affected, which can cause reproductive failures of pigs and horse nerve problems. Dr. Monas pointed out: “The introduction of Japanese encephalitis into the United States will pose a major threat, not only to public hygiene, but also pose a threat to the agricultural sector, especially the pig industry.” The potential increases the risk of outbreaks in the United States.
The possibility of Japanese encephalitis invading the United States further emphasizes mosquito transmission of viruses (such as the Sini River, Zika and Chikungunya), and these viruses have been established in the Americas. The geographical distribution of the Sini River was launched for the first time in 1999, and it is now almost included in the entire United States, which shows the potential for repeating the duplicate manifestations related to the closely related Japanese encephalitis virus. To explain this, in 2022, the disease went to the Australian continent, causing multiple outbreaks and deaths. This development prompts the risk of American authorities to evaluate the introduction of Japanese encephalitis, especially the risk of mosquito or mosquitoes transported through mosquitoes or passenger aircraft or cargo transportation.
Although no disease cases have been found in the United States, there are appropriate mosquito carriers, such as Culex pipiens and Adis White PhopicsThe extensive distribution of family and wild pigs has made the country a acceptance environment for the virus. The virus is separated from the pigs in the nose/oral secretion, and may spread between pigs without intermediate mosquito carriers. In particular, because it is close to the international port and its large pigs, it is considered a high risk. Dr. Monath emphasized: “The risk of establishing Japanese encephalitis in the United States is particularly high in ecological ingredients (Kellex mosquitoes, bird hosts and wild boars).”
Despite being threatened, preventive measures are still taken. The US Food and Drug Administration has approved a vaccine for human vaccine. However, there is currently no veterinarian vaccine in the United States. Pig is the key part of the virus transmission cycle, making it a key factor in controlling diseases. Dr. Monite explained: “Lack of veterinary vaccines is about veterinarians. The research requires other public health measures, including strengthening mosquito control work around pig farms and preparations for the deployment of fast vaccine.
In Australia, the outbreak of Japanese encephalitis in 2022 triggered an emergency response, including controlling mosquitoes in pigs and vaccination in dangerous people. If the virus is introduced, the United States may face similar challenges. The agricultural authorities have begun to prepare for the preparation of the pig industry and have taken human health measures, but experts warn that before these guarantee measures are fully effective, Japanese encephalitis may become an important public health emergency.
Dr. Monath emphasized the importance of rapid action at the time of outbreak. He said: “Quickly understanding and reaction is important to prevent Japanese encephalitis from being deeply rooted in the United States.” “Risk factor exists, and you should take Australia’s lessons seriously.” This study emphasized that a strong monitoring system and diagnostic ability detect the virus as soon as possible. And the development of new countermeasures, including antiviral drugs, is an improved vaccine that provides long -term immunity in humans and livestock and sufficient vaccine manufacturing capabilities, and this is a problem during the recent outbreak of Australia.
As the global spread of mosquito spreading the disease has continued to rise, the emergence of Japanese encephalitis is still a real possibility. Ensuring necessary preventive measures is essential to reduce the potential impact of public health and agriculture on public health and agriculture.
Journal reference
Monath, TP “Japanese encephalitis: risks in the United States and the influence of this.” Virus, 2024. Doi: https: //doi.org/10.3390/v16010054
About the author
Dr. Thomas Monath (Thomas Monath) He is an internationally renowned virusist and vaccist. He is known for viral encephalitis and virus hemorrhagic fever. He has 40 years of experience in senior positions in the biotechnology industry, and has played a leading role in the development of five vaccines. At present, he has been in Ebola virus, dengue fever, Japanese encephalitis and smallpox and smallpox, and to the Sinono River virus. Veterinary vaccine vaccine. Before joining the industry, Tom worked for 24 years in the US Army and the US Public Health Service. He has served as the director of the media to spread the virus disease and the head of the USAMRIID virus department. Tom received a doctorate degree in university degrees and medical degrees at Harvard University and received internal medicine training. He has won many prestigious awards, including Albert B. Sabin Gold Medal, and has served in many governments and international infectious diseases, biological safety committees, expert committees and national vaccine consulting committees (USA), and it was the past of the past. Former American Tropical Medicine and Health Society. He has published scientific papers and 6 books about Arbovirus and vaccine development.